London, UK, and Louisville, KY, USA: 3 February 2005 Cancer drug
developer Antisoma plc (LSE:ASM) announces that the shareholders of
Aptamera Inc yesterday approved Antisoma's acquisition of Aptamera.
All pre-closing conditions have now been satisfied or waived, save
for admission to the Official List and to trading on the London Stock
Exchange of the shares issued to effect the acquisition. Admission of
the shares and completion of the transaction are expected tomorrow, 4
February 2005.